Molecular dynamics simulations and classical multidimensional scaling unveil new metastable states in the conformational landscape of CDK2

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Pisani, Pasquale ^a   Caporuscio, Fabiana ^a   Carlino, Luca ^a   Rastelli, Giulio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; CYCLIN DEPENDENT KINASE 2; CDK2 PROTEIN, HUMAN;

ALPHA HELIX; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; MOLECULAR DYNAMICS; MULTIDIMENSIONAL SCALING; PROTEIN CONFORMATION; CHEMISTRY; HUMAN; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; CYCLIN-DEPENDENT KINASE 2; HUMANS; MOLECULAR DYNAMICS SIMULATION; PROTEIN CONFORMATION;

EID: 84964617582     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154066     Document Type: Article

References (52)

1. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002; 298:1912-1934. PMID: 12471243
2. Huse M, Kuriyan J. The conformational plasticity of protein kinases. Cell. 2002; 109:275-282. PMID: 12015977
3. Rabiller M, Getlik M, Klüter S, Richters A, Tückmantel S, Simard JR, et al. Proteus in the world of proteins: conformational changes in protein kinases. Arch Pharm (Weinheim). 2010; 343:193-206.
4. Taylor SS, Kornev AP. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci. 2011; 36:65-77. doi: 10.1016/j.tibs.2010.09.006 PMID: 20971646
5. Steichen JM, Iyer GH, Li S, Saldanha A, Deal MS, Woods VL, et al. Global consequences of activation loop phosphorylation on protein kinase A. J Biol Chem. 2010; 285:3825-3832. doi: 10.1074/jbc.M109.061820 PMID: 19965870
6. Knighton DR, Zheng JH, Ten Eyck LF, Ashford VA, Xuong NH, Taylor SS, et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 1991; 253:407-414. PMID: 1862342
7. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massagué J, et al. Mechanism of CDKactivation revealed by the structure of a cyclin A-CDK2 complex. Nature. 1995; 376:313-320 PMID: 7630397
8. Yamaguchi H, Hendrickson WA. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature. 1996; 384:484-489. PMID: 8945479
9. Canagarajah BJ, Khokhlatchev A, Cobb MH, Goldsmith EJ. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell. 1997; 90:859-869. PMID: 9298898
10. Endicott JA, Noble MEM, Johnson LN. The structural basis for control of eukaryotic protein kinases. Annu Rev Biochem. 2012; 81:587-613. doi: 10.1146/annurev-biochem-052410-090317 PMID: 22482904
11. Xu W, Doshi A, Lei M, Eck MJ, Harrison SC. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell. 1999; 3:629-638. PMID: 10360179
12. Levinson NM, Kuchment O, Shen K, Young MA, Koldobskiy M, Karplus M, et al. A Src-like inactive conformation in the abl tyrosine kinase domain. PLoS Biol. 2006; 4: e144. PMID: 16640460
13. Palmieri L, Rastelli G. αC helix displacement as a general approach for allosteric modulation of protein kinases. Drug Discov Today. 2013; 18:407-414. doi: 10.1016/j.drudis.2012.11.009 PMID: 23195331
14. Zuccotto F, Ardini E, Casale E, Angiolini M. Through the "gatekeeper door": exploiting the active kinase conformation. J Med Chem. 2010; 53:2681-2694. doi: 10.1021/jm901443h PMID: 20000735
15. Esposito L, Indovina P, Magnotti F, Conti D, Giordano A. Anticancertherapeutic strategies based on CDK inhibitors. Curr Pharm Des. 2013; 19:5327-5332. PMID: 23394082
16. Rizzolio F, Tuccinardi T, Caligiuri I, Lucchetti C, Giordano A. CDK inhibitors: from the bench to clinical trials. Curr Drug Targets. 2010; 11:279-290. PMID: 20210753
17. Endicott JA, Noble MEM Structural characterization of the cyclin-dependent protein kinase family. Biochem SocTrans. 2013; 41:1008-1016. doi: 10.1042/BST20130097 PMID: 23863171
18. Morgan DO Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol. 1997; 13:261-291. PMID: 9442875
19. Zhang J, Yang PL, Gray NS. Targeting cancerwith small molecule kinase inhibitors. Nat Rev Cancer. 2009; 9:28-39. doi: 10.1038/nrc2559 PMID: 19104514
20. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007; 408:297-315. PMID: 17850214
21. Li Y, Zhang J, Gao W, Zhang L, Pan Y, Zhang S, et al. Insights on structural characteristics and ligand binding mechanisms of CDK2. Int J Mol Sci. 2015; 16:9314-9340. doi: 10.3390/ijms16059314 PMID: 25918937
22. DeBondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO, Kim SH. Crystal structure of cyclindependent kinase 2. Nature. 1993;363:595-602. PMID: 8510751
23. Lawrie AM, Noble ME, Tunnah P, Brown NR, Johnson LN, Endicott JA. Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nat Struct Biol. 1997; 4:796-801. PMID: 9334743
24. Alexander LT, Möbitz H, Drueckes P, Savitsky P, Fedorov O, Elkins JM, et al. Type II Inhibitors targeting CDK2. ACS Chem Biol. 2015; 10:2116-2125. doi: 10.1021/acschembio.5b00398 PMID: 26158339
25. Betzi S, Alam R, Martin M, Lubbers DJ, Han H, Jakkaraj SR, et al. Discovery of a potential allosteric ligand binding site in CDK2. ACS Chem Biol. 2011; 6:492-501. doi: 10.1021/cb100410m PMID: 21291269
26. D'Abramo M, Besker N, Chillemi G, Grottesi A. Modeling conformational transitions in kinases by molecular dynamics simulations: achievements, difficulties, and open challenges. Front Genet. 2014; 5:128. doi: 10.3389/fgene.2014.00128 PMID: 24860596
27. De Vivo M, Bottegoni G, Berteotti A, Recanatini M, Gervasio FL, Cavalli A. Cyclin-dependent kinases: bridging their structure and function through computations. Future Med Chem. 2011; 3:1551-1559. doi: 10.4155/fmc.11.113 PMID: 21882947
28. Meng Y, Lin Y, Roux B. Computational study of the "DFG-flip" conformational transition in c-Abl and c-Src tyrosine kinases. J Phys Chem B. 2015; 119:1443-1456. doi: 10.1021/jp511792a PMID: 25548962
29. Berteotti A, Cavalli A, Branduardi D, Gervasio FL, Recanatini M, Parrinello M. Protein conformational transitions: the closure mechanism of a kinase explored by atomistic simulations. J Am Chem Soc. 2009; 131:244-250. doi: 10.1021/ja806846q PMID: 19067513
30. Torgerson WS Multidimensional Scaling: I. Theory and Method. Psychometrika. 1952; 17: 401-419.
31. Mardia KV Some properties of clasical multi-dimesional scaling. Commun Stat Methods. 1978; 7: 1233-1241.
32. Trosset MW, Priebe CE. The out-of-sample problem for classical multidimensional scaling. Comput Stat Data Anal. 2008; 52: 4635-4642.
33. Eckart C, Young G. The approximation of one matrix by another of lower rank. Psychometrika. 1936; 1: 211-218.
34. Jones E, Oliphant T, Peterson P, et al. SciPy: Open source scientific tools for Python. Available: http://www.scipy.org/
35. Jakalian A, Jack DB, Bayly CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem. 2002; 23:1623-1641. PMID: 12395429
36. Wang J, Wang W, Kollman PA, Case DA. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model. 2006; 25:247-60. PMID: 16458552
37. Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015; 11:3696-3713. doi: 10.1021/acs.jctc.5b00255 PMID: 26574453
38. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general Amber force field. J Comput Chem. 2004; 25:1157-1174. PMID: 15116359
39. Case DA, Berryman JT, Betz RM, Cerutti DS, Cheatham TE III, Darden TA, et al. AMBER 2015. San Francisco: University of California; 2015.
40. Darden T, York D, Pedersen L. Particle mesh Ewald: An N log(N) method for Ewald sums in large systems. J Chem Phys. 1993; 98:10089-10092.
41. Ryckaert JP, Ciccotti G, Berendsen HJ. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1977; 23: 327-341.
42. Miyamoto S, Kollman PA. SETTLE: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem. 1992; 13: 952-962.
43. Hamelberg D, Mongan J, McCammon JA. Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules. J Chem Phys. 2004; 120:11919-11929. PMID: 15268227
44. Bakan A, Meireles LM, Bahar I. ProDy: protein dynamics inferred from theory and experiments. Bioinformatics. 2011; 27:1575-1577. doi: 10.1093/bioinformatics/btr168 PMID: 21471012
45. Roe DR, Cheatham TE. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013; 9:3084-3095. doi: 10.1021/ct400341p PMID: 26583988
46. Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph. 1996; 14:33-38. PMID: 8744570
47. Python Software Foundation. Python Language Reference, version 2.7. Python Software Foundation. 2013. Available: http://www.python.org
48. Van Der Walt S, Colbert SC, Varoquaux G. The NumPy array: a structure for efficient numerical computation. Comput Sci Eng. 2011; 13: 22-30.
49. Shukla D, Meng Y, Roux B, Pande VS. Activation pathway of Src kinase reveals intermediate states as targets for drug design. Nat Commun. 2014; 5: 3397. doi: 10.1038/ncomms4397 PMID: 24584478
50. Yang S, Banavali NK, Roux B. Mapping the conformational transition in Src activation by cumulating the information from multiple molecular dynamics trajectories. Proc Natl Acad Sci USA. 2009; 106:3776-3781. doi: 10.1073/pnas.0808261106 PMID: 19225111
51. Levy Y, Becker OM. Energy landscapes of conformationally constrained peptides. J Chem Phys. 2001; 114: 993-1009.
52. Meng Y, Roux B. Locking the active conformation of c-Src kinase through the phosphorylation of the activation loop. J Mol Biol. 2014; 426:423-435. doi: 10.1016/j.jmb.2013.10.001 PMID: 24103328